Hepcidin was suppressed in non‐iron deficient β‐thalassemia trait carriers (4.1 ng/mL) compared with non‐iron deficient children without hemoglobinopathy (5.2 ng/mL, P < 0.001) (Supporting Information Table I). This evidence concerns the gene HAMP and hemoglobinopathy.